Clinical Trial Details

Trial ID: L0281
Source ID: NCT04173065
Associated Drug: VK2809
Title: A Study to Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASH
Acronym: VOYAGE
Status: Recruiting
Study Results: No Results Available
Results: --
Conditions: NASH - Nonalcoholic Steatohepatitis
Interventions: Drug: VK2809|Drug: Placebos
Outcome Measures: Liver Fat|NASH CRN fibrosis score
Sponsor/Collaborators: Viking Therapeutics, Inc.
Gender: All
Age: 18 Years to 75 Years ?? (Adult, Older Adult)
Phases: Phase 2
Enrollment: 337
Study Type: Interventional
Study Designs: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment
Start Date: November 15, 2019
Completion Date: December 2022
Results First Posted: --
Last Update Posted: March 3, 2022
Locations: Viking Clinical Site 206, Birmingham, Alabama, United States|Viking Clinical Site 105, Madison, Alabama, United States|Viking Clinical Site 212, Chandler, Arizona, United States|Viking Clinical Site 216, Glendale, Arizona, United States|Viking Clinical Site 159, Tucson, Arizona, United States|Viking Clinical Site 214, North Little Rock, Arkansas, United States|Viking Clinical Site 161, Fresno, California, United States|Viking Clinical Site 208, Fresno, California, United States|Viking Clinical Site 302, La Jolla, California, United States|Viking Clinical Site 305, Los Angeles, California, United States|Viking Clinical Site 204, Los Angeles, California, United States|Viking Clinical Site 134, Montclair, California, United States|Viking Clinical Site 205, Panorama City, California, United States|Viking Clinical Site 125, Pasadena, California, United States|Viking Clinical Site 110, Rialto, California, United States|Viking Clinical Site 117, Sacramento, California, United States|Viking Clinical Site 121, San Diego, California, United States|Viking Clinical Site 316, San Francisco, California, United States|Viking Clinical Site 103, San Francisco, California, United States|Viking Clinical Site 154, Tustin, California, United States|Viking Clinical Site 135, Aurora, Colorado, United States|Viking Clinical Site 202, Englewood, Colorado, United States|Viking Clinical Site 156, New Haven, Connecticut, United States|Viking Clinical Site 226, Bradenton, Florida, United States|Viking Clinical Site 150, Lakewood Ranch, Florida, United States|Viking Clinical Site 221, Miami Lakes, Florida, United States|Viking Clinical Site 106, Miami, Florida, United States|Viking Clinical Site 132, Miami, Florida, United States|Viking Clinical Site 301, Miami, Florida, United States|Viking Clinical Site 310, Miami, Florida, United States|Viking Clinical Site 131, Pensacola, Florida, United States|Viking Clinical Site 215, Port Orange, Florida, United States|Viking Clinical Site 218, Sarasota, Florida, United States|Viking Clinical Site 139, Zephyrhills, Florida, United States|Viking Clinical Site 144, Atlanta, Georgia, United States|Viking Clinical Site 306, Atlanta, Georgia, United States|Viking Clinical Site 111, Marietta, Georgia, United States|Viking Clinical Site 315, Honolulu, Hawaii, United States|Viking Clinical Site 129, Chicago, Illinois, United States|Viking Clinical Site 120, Indianapolis, Indiana, United States|Viking Clinical Site 130, South Bend, Indiana, United States|Viking Clinical Site 211, West Des Moines, Iowa, United States|Viking Clinical Site 145, Topeka, Kansas, United States|Viking Clinical Site 146, Marrero, Louisiana, United States|Viking Clinical Site 307, New Orleans, Louisiana, United States|Viking Clinical Site 166, West Monroe, Louisiana, United States|Viking Clinical Site 109, Baltimore, Maryland, United States|Viking Clinical Site 107, Greenbelt, Maryland, United States|Viking Clinical Site 147, Boston, Massachusetts, United States|Viking Clinical Site 151, Plymouth, Massachusetts, United States|Viking Clinical Site 158, Ann Arbor, Michigan, United States|Viking Clinical Site 133, Detroit, Michigan, United States|Viking Clinical Site 213, Jackson, Mississippi, United States|Viking Clinical Site 112, Kansas City, Missouri, United States|Viking Clinical Site 217, Kansas City, Missouri, United States|Viking Clinical Site 160, Las Vegas, Nevada, United States|Viking Clinical Site 223, Reno, Nevada, United States|Viking Clinical Site 152, New York, New York, United States|Viking Clinical Site 128, Rochester, New York, United States|Viking Clinical Site 314, Chapel Hill, North Carolina, United States|Viking Clinical Site 141, Charlotte, North Carolina, United States|Viking Clinical Site 126, Concord, North Carolina, United States|Viking Clinical Site 116, Durham, North Carolina, United States|Viking Clinical Site 153, Morehead City, North Carolina, United States|Viking Clinical Site 137, Cincinnati, Ohio, United States|Viking Clinical Site 108, Cleveland, Ohio, United States|Viking Clinical Site 148, Philadelphia, Pennsylvania, United States|Viking Clinical Site 313, Philadelphia, Pennsylvania, United States|Viking Clinical Site 311, Pittsburgh, Pennsylvania, United States|Viking Site 155, Charleston, South Carolina, United States|Viking Clinical Site 127, Greenville, South Carolina, United States|Viking Clinical Site 227, Clarksville, Tennessee, United States|Viking Clinical Site 118, Hermitage, Tennessee, United States|Viking Clinical Site 115, Arlington, Texas, United States|Viking Clinical Site 113, Dallas, Texas, United States|Viking Clinical Site 220, Edinburg, Texas, United States|Viking Clinical Site 225, El Paso, Texas, United States|Viking Clinical Site 142, Houston, Texas, United States|Viking Clinical Site 102, San Antonio, Texas, United States|Viking Clinical Site 104, San Antonio, Texas, United States|Viking Clinical Site 101, San Antonio, Texas, United States|Viking Clinical Site 143, San Antonio, Texas, United States|Viking Clinical Site 201, San Antonio, Texas, United States|Viking Clinical Site 224, Ogden, Utah, United States|Viking Clinical Site 163, Falls Church, Virginia, United States|Viking Clinical Site 304, Newport News, Virginia, United States|Viking Clinical Site 209, Richmond, Virginia, United States|Viking Clinical Site 312, Richmond, Virginia, United States|Viking Clinical Site 317, Seattle, Washington, United States|Viking Clinical Site 501, Wilrijk, Van, Belgium|Viking Clinical Site 503, Brussels, VBR, Belgium|Viking Clinical Site 502, Brussels, Belgium|Viking Clinical Site 611, Amiens Cedex 1, France|Viking Clinical Site 602, Clichy, France|Viking Clinical Site 612, Cr??teil, France|Viking Clinical Site 610, Grenoble, France|Viking Clinical Site 609, Montpellier, France|Viking Clinical Site 607, Paris, France|Viking Clinical Site 603, Paris, France|Viking Clinical Site 605, Paris, France|Viking Clinical Site 608, Strasbourg, France|Viking Clinical Site 601, Vand??uvre-l??s-Nancy, France|Viking Clinical Site 604, Villejuif, France|Viking Clinical Site 401, Acapulco, GRO, Mexico|Viking Clinical Site 402, Cuernavaca, MOR, Mexico|Viking Clinical Site 422, Monterrey, NLE, Mexico|Viking Clinical Site 421, Ciudad de mexico, Mexico|Viking Clinical Site 219, San Juan, Puerto Rico
URL: https://ClinicalTrials.gov/show/NCT04173065

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress
D513 VK2809 Chemical drug DB15137 THR-β agonist -- Under clinical trials Details